Gurudutt P. Varty
@DrGuruduttVarty
Followers
623
Following
1K
Media
18
Statuses
294
MS, DNB, MCh (Surgical Gastroenterology) PDF (HPB Oncosurgery, TMH), Fellowship (MIS HPB Surgery, Severance Hospital, Seoul)
Mumbai, India
Joined December 2009
Delighted, our study features in the premier jrnl of Sx @AnnalsofSurgery. Thnk you for the constant guidance @Manishbhandare4 Thnk you for the opportunity @Shrikhande_SV
@DrRaviChandra without you my frnd the huge data compilation ws a distant dream @IHPBA @DrVAChaudhari
CA 19-9 is of great value in Ampullary cancers too Should be a routine surveillance test Our work to feature in @AnnalsofSurgery for the 1st time, hoping this to be a good beginning @DrGuruduttVarty special congratulations to you 🤝👍 https://t.co/AzwaO8yS1M
@Shrikhande_SV
3
0
7
An incredible masterclass by the Stalwarts... Flawless live demonstration of the intricate nuances of Robotic right hepatectomy by Prof. Choi A truly enriching learning feast.. #Oncosurg25! @drmgoel @Shraddha_234 @DrGuruduttVarty @DrVAChaudhari @pankajch37
1
9
20
4 days for this stellar event!!
Oncosurg 2025, 4 days to go Registration link- https://t.co/XDxMsJqRQj
@TataMemorial @ACTREC_TMC @Shrikhande_SV @cspramesh @MahendraTMH @drsabita @drgaganprakash @DrVAChaudhari @drmgoel @Shraddha_234 @dnair78 @MufaddalKazi @aamirparray18 @dramandeeparora @drshalakajoshi
0
2
2
Oncosurg 2025, 4 days to go Registration link- https://t.co/XDxMsJqRQj
@TataMemorial @ACTREC_TMC @Shrikhande_SV @cspramesh @MahendraTMH @drsabita @drgaganprakash @DrVAChaudhari @drmgoel @Shraddha_234 @dnair78 @MufaddalKazi @aamirparray18 @dramandeeparora @drshalakajoshi
1
10
13
@APHPBA 2025 was a highly successful meeting. Grateful for the opportunity to contribute and proud of the scientific discussions we advanced. Enjoyed the engaging sessions, reconnecting with colleagues. @Shrikhande_SV @DrPJagannath @DrVAChaudhari
3
6
41
India must lead the way in GB cancer research. Congratulations to the team on the successful completion of this trial and win! @TataMemorial @ACTREC_TMC
🏆 Big win at #APHPBA2025! The POLCAGB Trial clinches Best Paper Award at the Plenary Session! 💡 Concurrent chemoradiation + chemotherapy shows improved survival & resection outcomes in locally advanced gallbladder cancer. @shraddha_234 @APHPBA
0
2
3
A surgical extravaganza, not to missed! @OncoShravan @Saneya_2810 @dramitchopde @iamThe_Surgeon @Kaival_Gundavda @DrNiketMShah @lddcmumbai @gunjandesai13 @SanjayGovil8
Less than 4 weeks to go for Oncosurg 2025 20–22 November | ACTREC–TMC, Navi Mumbai Abstract submission (Video category) extended till 30th October 2025 Join us for live cancer surgeries, global experts and cutting-edge discussions Register now: https://t.co/OZ1NsxMuno
2
1
7
New to reading CT Abdomen? Start here! A step-by-step guide using the ABCT mnemonic to simplify your approach. Watch now: https://t.co/aBFOvXXqHZ Do share to colleagues @drkeithsiau @DrGuruduttVarty @StanfordGenSurg #MedTwitter #GITwitter
0
6
8
What next? ➡️ Prospective validation across centers ➡️ Integration with radiomics & molecular markers ➡️ Use as a decision-support tool for MDTs Remember, Biology 'is', 'was' and 'always will' remain the king!
0
0
2
In summary: 11% of resections were futile High CA19–9, BR-GBC, and extended resections predict futility Nomogram helps preoperatively identify patients unlikely to benefit “Primum non nocere” — first, do no harm
1
1
3
🔍 Predictors of FS 1️⃣ log CA 19–9 ↑ (OR 1.12, p=0.014) 2️⃣ Borderline/Locally Advanced GBC (OR 1.97, p=0.001) 3️⃣ Extended or Multivisceral Resection (OR 2.01, p=0.014 Nomogram 👇🏽 Example: High CA19–9 + BR-GBC + planned multivisceral resection → ~33% risk of futile surgery.
1
1
1
Standard management protocol at TMH as per the TMH criteria by @DrVAChaudhari et al. Patients divided into early and borderline resectable GBC. BR-GBC - 344 (28.8%) offered Neoadjuvant treatment. Rest early GBC - upfront surgery
1
0
1
Cohort: 1196 resected gallbladder adenocarcinomas (2010–2023) Largest single-center GBC dataset (Tata Memorial Hospital, India 🇮🇳) Excluded R2/inoperable cases Only preoperative factors analyzed. @skmaithel @HPBCambridge @SirohiBhawna @drsadiqs @OncoShravan @TorzilliGuido
1
0
1
💡 Why this matters: GBC is an aggressive disease. Despite “curative” resection, many patients recur or die within months — questioning the value of surgery. We defined “Futile Surgery (FS)” as recurrence or death within 6 months after resection. @EAVegaMD @timpawlik @ItaruEndo
1
1
2
🚨New from TMH! Can we predict futile Surgery in resectable gallbladder cancers? Our findings published in @ejsotweets Link👇🏽 https://t.co/6GTc7L2nUY Resectable ≠ Beneficial @Shraddha_234 @drmgoel @Hepbilisurg_TMH Thread👇🏽 @Shrikhande_SV @cspramesh @TataMemorial
3
20
41
Do watch to know the evolution and nuances of pancreatic cancer surgery in India!!
Wonderful conversation with @Shrikhande_SV on his passion and hardwork with pancreas...
0
0
1
Wonderful conversation with @Shrikhande_SV on his passion and hardwork with pancreas...
1
6
5
@ISGPS_news @APHPBA @EAHPBA @for_surgeons @OncoShravan @aamirparray18 @Manishbhandare4 @DrGuruduttVarty @DrVAChaudhari
@drsadiqs Thank you so much. Enjoyed revisiting the journey of pancreas surgery over 2 decades. Truly honoured!
0
2
2
👉🏻 don’t miss this one!
⏳ 8 weeks to go! ONCOSURG 2025 | 20–22 Nov | @ACTREC_TMC Theme: Balancing Oncological Safety with Function Preservation 🔹 18–20 live cancer surgeries 🔹 Robotic liver & thyroid surgeries (Intl faculty) 🔹 Hands-on workshops & video awards 👉 Register: https://t.co/52YNWPodOy
0
4
10
@edusurg_clinics @gunjandesai13 @INASL_Liver @IHPBA @StanfordSurgery @ACTREC_TMC Precision in action 🏥🔪 is the key Right Hepatectomy – Surgical Demonstration A step-by-step look at safe liver resection. 🎥 Watch here: https://t.co/Y2bebx9aK5
#GITwitter #MedTwitter @DrGuruduttVarty @LiverSurgSanRaf @StanfordGenSurg
1
2
3